Etonogestrel

依托孕烯

Report date: 2026/05/13 20:02:10
NME

Base Information

Drug NameEtonogestrel
Drug Alias NameetonogestreletonogestrelumNexplanonImplanonImplanon/Nexplanon +[6] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionProgesterone receptor agonistsEstrogen receptors agonists
TargetsEstrogen receptorsProgesterone receptor
Therapy Area/IndicationsContraceptionDysmenorrheaMenstruation Disturbances +[6] 
Global Approved IndicationsContraception
Approved Indications in ChinaContraception
Original Approved Country/TerritoryNetherlands
Original Approved Date1998/08/25
Country/TerritoryCanadaUnited StatesUganda +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesOrganon
China Registration ClassN/A

Develop Information

Active CompaniesOrganon Usa IncN.V. OrganonUniversity of Nebraska +[4] 
Inactive CompaniesOrganonOregon Health And Science UniversityYale University +[8] 
Active IndicationsContraceptionAcquired Immunodeficiency Syndrome
Inactive IndicationsDysmenorrheaMenstruation DisturbancesMetrorrhagia +[4] 

Other Information

ATC CodeG03AC08
Related LinksWikipediaDrugBankKEGG